Isomerase helps partners innovate and harness the microbial power of a wide range of bacteria and fungi to discover and produce native or novel natural products, peptides, and enzymes sustainably, cost effectively and at scale.
Isomerase leverages its decades of experience working with bacteria and fungi, combined with its knowledge, capabilities and innovations in biology, chemistry, and bioprocessing, to enable partners to progress their products and processes toward commercialisation.
Company Details
- Employees
- 35
- Founded
- -
- Address
- Chesterford Research Park, Cambridge,cb10 1xl,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- isomerase.co.uk
- Keywords
- analogue generation, analytical chemistry, biocatalysis, bioinformatics, biomanufacturing, bioprocess development, consulting services, enzyme engineering, fermentation, microbial strains, natural product chemistry, natural products, peptides, proteins, scale-up, strain bioengineering, sustainability, synthetic biology, tech transfer, USP and DSP development, enzyme discovery.
- HQ
- Cambridge
Isomerase Questions
Isomerase's website is isomerase.co.uk
Isomerase's LinkedIn profile is https://uk.linkedin.com/company/isomerase
Isomerase has
35 employees.
View email and phone details for 35
employees at Isomerase.
Isomerase's industry is
Biotechnology Research
Isomerase's top competitors are
Cryptobiotix,
Labgenius Therapeutics,
Constructive Bio,
Isogenica,
Bactobio,
Bicycle Therapeutics,
Healx,
Syndex Bio,
Cambridge Glycoscience,
Bugbiome.
Isomerase's categories are Biotechnology Research
Isomerase's founding year is 2012
